Please ensure Javascript is enabled for purposes of website accessibility

Why Danimer Scientific Stock Fell 17% at the Open Today

By Reuben Gregg Brewer - Mar 30, 2021 at 11:04AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Danimer Scientific didn't get a particularly warm reception as it reported earnings for the very first time.

What happened

Shares of Danimer Scientific (DNMR -8.52%) dropped a quick 17% as trading got underway on March 30. The news likely driving the decline was the company's after-the-market earnings release on March 29, the first quarterly report of its public life.  

So what

Danimer Scientific, which is involved in making biodegradable plastics, came public through a blank check company in the last few trading days of 2020. That means its fourth-quarter 2020 earnings report was its first as a public entity, though for most of the period it wasn't actually public. Basically, this report is setting something of a benchmark for future periods. Investors don't seem to be too pleased with the results.  

A man with his head on table and a graph behind him heading down.

Image source: Getty Images.

Danimer Scientific had revenues of around $12 million, up from $8.7 million in the same period of 2019. While that's not too bad, it lost $11.2 million in the fourth quarter of 2020, up from a loss of $3.3 million a year earlier. To be fair, the transition from private to public isn't a simple one, and the quarter included some one-time costs associated with the decision. However, management made a point of noting that it is seeing strong demand for its products and augmented its plans to build a new facility that won't even break ground until 2022 (and won't be operational until mid-2023). So it's highly likely that the red ink will continue here, given the modest top-line numbers and capital spending needs. Coming public has left the company flush with cash ($377 million at the end of 2020), and it clearly has plans for the money, but the new facility won't bear fruit for another couple of years. That's a long time to wait on Wall Street.  

Now what

Danimer Scientific is an interesting company, for sure, but it's kind of hard to understand how it has a $2.8 billion market cap given the size of its actual business and the fact that there's no particular indication that profits are near at hand. Though to be fair, management is projecting a "significant ramp up" in revenue in 2021.  

Still, now that the company has reported earnings for the first time, perhaps investors are starting to wonder if the multibillion-dollar valuation being afforded to Danimer Scientific really makes sense. Including today, the stock has already lost around half of its value since hitting a price peak in early February. It seems as though the special purpose acquisition vehicle (SPAC) pixie dust may be starting to wear off. Conservative long-term investors will probably want to stay on the sidelines until the company has a longer track record as a public entity, and perhaps even until that new facility is operational in 2023. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Danimer Scientific, Inc. Stock Quote
Danimer Scientific, Inc.
DNMR
$4.03 (-8.52%) $0.38

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
334%
 
S&P 500 Returns
117%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.